Oropharyngeal Cancer

Oropharyngeal cancer is a malignant cancer that forms in the tissues of the oropharynx (the middle part of the throat).

Programs + Services

Head + Neck Cancer Center

Visit the Head and Neck Cancer Center to find out more about treatment for all head and neck cancers, including mouth (oral) and throat cancer.
More information about programs and services

Doctors + Care Team

Miriam O'Leary, MD, FACS
Request Appointment for Miriam O'Leary, MD, FACS

Miriam O'Leary, MD, FACS

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): Chair, Department of Otolaryngology, Tufts Medical Center; Otolaryngologist; Chair and Associate Professor, Department of Otolaryngology, Tufts University School of Medicine
Department(s): Otolaryngology
Appt. Phone: 617-636-3030
Fax #: 617-636-1479

Head and neck cancer, management of thyroid cancer and hyperparathyroidism, head and neck reconstruction including microvascular techniques, management of radiation-related complications

View Full Profile for Miriam O'Leary, MD, FACS
Richard O. Wein, MD, FACS
Request Appointment for Richard O. Wein, MD, FACS

Richard O. Wein, MD, FACS

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): Chief, Division of Head and Neck Surgery; Associate Professor, Tufts University School of Medicine
Department(s): Otolaryngology
Appt. Phone: 617-636-8711
Fax #: 617-636-1479

Head and neck surgical oncology, head and neck reconstruction, management of salivary and thyroid disorders, management of radiation-related complications, maxillofacial trauma, sleep apnea and sleep endoscopy

View Full Profile for Richard O. Wein, MD, FACS

Research + Clinical Trials

EA3161: A Phase III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Rsik HPV Positive OPSCC

This study is being done to answer the following question:

Does maintenance nivolumab following definitive therapy with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (OS) (time being alive) for patients with your type of cancer (intermediate risk HPV positive oropharynx cancer).

We are doing this study because we want to find out if this approach is better or worse than the usual approach for your HPV positive oropharynx cancer. The usual approach is defined as care most people get for HPV positive oropharynx cancer.


More information about research and clinical trials